|
|
|
|
|
Name |
|
Dr.
Santasabuj Das |
|
 |
|
|
|
Educational Qualification |
|
MD (General Medicine) |
|
 |
|
|
|
Date of birth |
|
8th January, 1967 |
|
 |
|
|
|
Designation |
|
Principal Investigator & Coordinator |
|
 |
|
|
|
Division |
|
Clinical Medicine |
|
 |
|
|
| |
E-mail |
|
santasabujdas@yahoo.com |
| |
 |
|
|
| |
Specialization |
|
Molecular immunology and signal
transduction |
| |
 |
|
|
| |
Date of joining ICMR |
|
28th January, 2005 |
| |
 |
|
|
| Professional Experience
:
I graduated in medical sciences (MBBS) in 1989 from the University of
Calcutta and completed my post-graduation (MD, General Medicine) in 1996
from the same university. After a brief exposure to the basic research
in immunology at Indian Institute of Chemical Biology, Kolkata, India, I
joined the Department of Clinical Immunology at Sanjay Gandhi
Post-graduate Institute of Medical Sciences, Lucknow, India as a senior
resident (clinical) and worked there for about one year. I was involved
in the diagnosis and management of patients suffering from autoimmune
diseases and immune cell (hematological) malignancies. My career in
laboratory research started at National Center for Biological Sciences (NCBS),
Tata Institute of Fundamental Research (TIFR), Bangalore, India where I
joined as a visiting post-doctoral fellow in late 1998. During my one
and a half years of stay at NCBS, I worked on the role of Notch
signaling in cervical carcinogenesis. I moved to USA for further
post-doctoral training in the year of 2000 and joined the laboratory of
Prof. Philip N. Tsichlis, the Director of the Basic Sciences Division at
Kimmel Cancer Centre, Thomas Jefferson University, Philadelphia,
Pennsylvania. I worked there on the transcriptional regulation of MHC
Class II genes and showed that a particular domain of the transcription
factor Tvl-1/RFXANK is required for the formation of a stable RFX
transcriptome. During the later part of my post-doctoral training at the
Molecular Oncology Research Institute under Tufts-New England Medical
Center, Boston, Massachusetts, I studied the role of Tpl2, an upstream
MAPKinase, in the pro-inflammatory cytokine (TNF- and IL-1)-induced
signal transduction. Our study proved that Tpl2-mediates the activation
of MAPKinases and NF-B by TNF- and IL-1-induced signals in a
cell-type and stimulus specific manner and that both the adaptor
molecules TRAF2 and RIP-1 are required for transduction of TNF- signals
by Tpl2. I was also a co-investigator in the studies that showed that
TNF--induced Tpl2 activating signals are also mediated by tyrosine
kinase syk and Tpl2 is critically important in the pancreatic and lung
inflammation during acute pancreatitis
Research Interests:
The area of my current research interest is mucosal innate immune
responses.
- Regulation of antimicrobial peptide (AMP) expression: AMPs are small
cationic proteins that form a critical component of the host innate
immune system and protect the body from pathogens that invade through
the mucosal surfaces. Published reports suggest that downregulation of
the AMPs may serve as an efficient mode of immune evasion by the mucosal
pathogens; however, neither the pathogen-derived factors nor the
mechanism of downregulation is currently known. We have recently shown
that cholera toxin and LT may transcriptionally downregulate
cathelicidin and human -defensin 1 expression in the intestinal
epithelial cells by inducing multiple intracellular signal transduction
pathways (In press). We are currently trying to identify the
transcription factors that regulate the basal or inducible production of
the AMPs. Studies on AMP regulation by other PAMPs like bacterial
flagellin and viral double-stranded RNAs are also underway.
- Pattern recognition receptor (PRR) signaling: PRRs (TLRs and NLRs)
have been identified as the key molecules for innate recognition of
pathogenic microorganisms. Bacterial motility protein flagellin binds to
TLR5 on the cell surface. Although the crystal structure of TLR5/flagellin
interaction is not resolved, genetic and biochemical approaches have
identified the interacting domains as well as several critical residues
required for the interaction. However, the downstream signaling
mechanisms have not been studied in detail. We have found that different
intracellular signaling pathways are activated by flagellins of
different origins. We are trying to identify the factors that determine
the recruitment of specific signaling molecules. Simultaneously, we are
dissecting the signaling pathways and subsequent regulation of gene
expression.
- Epithelial differentiation induced regulation of mucosal immune
response: Considering the unique disposition of epithelial cells in the
intestinal wall with gradually increased differentiation towards the
lumen, epithelial differentiation may significantly contribute towards
maintaining the intestinal homeostasis and simultaneously preventing the
pathogens to invade the body. Studies published by different groups have
shown that the expression of immune recognition receptors (eg, TLRs) as
well as immune effector molecules (cytokines, chemokines, antimicrobial
peptides etc) may be altered in the differentiated cells; however, the
mechanisms remain largely unexplored. Using butyrate-induced epithelial
differentiation model, we are studying transcriptional regulation of the
genes that have significantly altered expression in the differentiated
cells.
- Host-pathogen interactions in human salmonella infection: The
virulence factors described till date fail to account for the entire
spectrum of human diseases that include both inflammatory diarrhea and
enteric fever caused by the salmonella spp. Using bioinformatic and wet
laboratory (genetic and biochemical) approaches as well as the animal
models, we are trying to identify novel virulence factors of salmonella
spp that infect humans and their role in the pathogenesis.
- Role of microRNAs in chronic hepatitis and HIV/AIDS: microRNAs are
small (18-25 nt) non-coding RNAs that have recently been identified to
play a major role in gene regulation. Although, several HIV-1 and
hepatitis B-encoded microRNAs have been described and host miRNA
expression pattern has been proposed to be altered during infection with
these viruses, the precise role of either host or virus-encoded miRNAs
in the pathogenesis remains unexplored. We are trying to identify the
miRNAs that may be involved in host-pathogen interaction during
hepatitis B and HIV-1 infection.
Projects
Intramural :
-
Exploring the Mechanism of the Immunomodulatory Functions of
Cholera Toxin
Extramural :
-
Biomedical Informatics Center of ICMR (Indian council of Medical
Research)
-
Identification and Distribution of HIV-1 Encoded MicroRNAs in
North-east Indian Population (Indian council of Medical Research)
-
A Study on Differentiation-induced Regulation of the Immune
Response Related Genes in the Intestinal Epithelial Cells (Indian
council of Medical Research)
-
A Study on the Regulation of Antimicrobial Peptide Expression in
the Intestinal Epithelial Cells (Okayama University, Japan)
Pre-doctoral Students :
-
Mr. Krishnendu Chakraborty (Pre-doctoral)
-
Mr. Subhamoy Ghosh (Pre-doctoral)
-
Mr. Theya Nagaraja (Pre-doctoral)
-
Ms. Rima Tapadar (Pre-doctoral)
-
Ms. Pujarini Datta (Pre-doctoral
Memberships /Fellowships:
Indian Science Congress Association (2005).
|
|
|
[2009] |
|
| 1 |
Sinha, N. K., A. Roy, B. Das, S. Das
and S. Basak. 2009. Evolutionary complexities of swine flu H1N1
gene sequences of 2009. Biochem Biophys Res Commun. 390:
349-51. |
 |
|
|
|
| 2 |
Chakraborty, K., P. C. Maity, A. K. Sil, Y.
Takeda and S. Das. 2009. cAMP stringently regulates human
cathelicidin antimicrobial peptide expression in the mucosal epithelial
cells by activating cAMP-response element-binding ptotrin, AP-1, and
Inducible cAMP early repressor. J Biol Chem. 284:21818-21827. |
 |
|
|
|
| 3 |
Basak S., R. Banerjee, I. Mukherjee, S. Das.
2009. Influence of domain architecture and codon usage pattern on
the evolution of virulence factors of Vibrio cholerae. Biochem Biophys
Res Commun. 379:803-805. |
|
|
|
|
|
[2008] |
|
| 4 |
Basak S., I. Mukherjee, M. Choudhury and S.
Das. 2008. Unusual codon usage bias in low expression genes of
Vibrio cholerae. Bioinformation. 3:213-217. |
|
|
|
|
| 5 |
Chakraborty K., S. Ghosh, H. Kole, A. K.
Mukhopadhyay, T. Ramamurthy, D. R. Saha, D. Mukhopadhyay, S.
Roychowdhury, T. Hamabata, Y. Takeda and S. Das. 2008. Bacterial
exotoxins downregulate cathelicidin (hCAP18/LL37) and human -defensin 1
(HBD-1) expression in the intestinal epithelial cells. Cell Microbiol.
10:2520-2537 |
|
|
|
|
|
[2007] |
|
| 6 |
Van Acker G. J., G. Perides, E. R. Weiss, S.
Das, P. N. Tsichlis and M. L. Steer. 2007. Tumor progression
locus-2 is a critical regulator of pancreatic and lung inflammation
during acute pancreatitis. J Biol Chem. 282:22140-9. |
|
|
|
|
|
[2006] |
|
| 7 |
Ghosh A., D. R. Saha, K. M. Hoque, M.
Asakuna, S. Yamazaki, H. Koley, S. Das, M. K. Chakraborty and A. Pal.
2006. Enterotoxigenicity of 45kDa matured and 35kDa processed forms
of hemagglutinin protease purified from a cholera toxin gene negative
Vibrio cholerae non-O1non-O139 strain. Infect Immun. 74:2937-46. |
|
|
|
|
| 8 |
Eliopoulos A. G., S. Das and P. N. Tsichlis.
2006. The tyrosine kinase Syk regulates TPL2 activation signals. J
Biol Chem. 281:1371-80. |
|
|
|
|
|
[2005] |
|
| 9 |
Das S., J. Cho, I. Lambertz, M. A. Kelliher,
A. G. Eliopoulos, K. Du and P. N. Tsichlis. 2005. Tpl2/Cot
Signals Activate ERK, JNK, and NF-B in a Cell-type and
Stimulus-specific Manner. J Biol Chem. 280:23748-57. |
|
|
|
|
|
[2002] |
|
| 10 |
Das S, J. H. Lin, J. Papamatheakis, Y.
Sykulev and P. N. Tsichlis. 2002. Differential splicing generates
Tvl-1/RFXANK isoforms with different functions. J Biol Chem. 277:45172-80. |
|
|
|
|
|